Nephros, Inc.
NEPH
$2.91
$0.134.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.20% | 35.42% | 35.89% | 38.47% | 18.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.20% | 35.42% | 35.89% | 38.47% | 18.93% |
| Cost of Revenue | 41.08% | 35.06% | 21.19% | 29.06% | 13.14% |
| Gross Profit | 11.56% | 35.64% | 46.18% | 44.22% | 22.46% |
| SG&A Expenses | 23.72% | 29.52% | 13.40% | 5.23% | -22.36% |
| Depreciation & Amortization | -5.88% | 0.00% | 2.94% | 18.18% | -33.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.59% | 34.36% | 16.87% | 15.82% | -8.97% |
| Operating Income | -94.32% | 52.43% | 178.23% | 383.00% | 148.84% |
| Income Before Tax | -82.97% | 85.79% | 185.12% | 430.18% | 155.66% |
| Income Tax Expenses | -100.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -82.23% | 84.15% | 182.01% | 430.18% | 153.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.23% | 84.15% | 182.01% | 430.18% | 153.36% |
| EBIT | -94.32% | 52.43% | 178.23% | 383.00% | 148.84% |
| EBITDA | -85.80% | 45.61% | 199.65% | 465.06% | 158.86% |
| EPS Basic | -82.48% | 82.76% | 181.45% | 426.71% | 153.04% |
| Normalized Basic EPS | -83.33% | 85.19% | 184.30% | 425.74% | 155.38% |
| EPS Diluted | -82.48% | 72.41% | 166.67% | 350.00% | 153.04% |
| Normalized Diluted EPS | -83.80% | 77.78% | 182.56% | 425.74% | 155.38% |
| Average Basic Shares Outstanding | 0.98% | 0.64% | 0.90% | 0.94% | 0.54% |
| Average Diluted Shares Outstanding | 6.15% | 4.35% | 2.88% | 1.09% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |